Women with metastatic breast cancer, receiving first line treatment of any kind
(chemotherapy, endocrine treatment or treatment with antibodies) will be included in this
trial. In connection to treatment, blood samples for determination and enumeration of
circulating tumour cells will be collected at different time points. Serum and plasma will be
collected and stored for future analysis of RNA and DNA.